Helicobacter pylori: Basic Mechanisms to Clinical Cure 1998

Front Matter....Pages i-xx
Front Matter....Pages 1-1
New Helicobacter species....Pages 3-12
The origin of virulence in type I strains of Helicobacter pylori ....Pages 13-18
 vacA polymorphism....Pages 19-26
The interaction of cag + Helicobacter pylori strains with their hosts....Pages 27-32
Molecular mimicry between Helicobacter pylori and the host....Pages 33-42
Considerations of virulence by Helicobacter pylori ....Pages 43-48
Front Matter....Pages 49-49
The faecal-oral route - a critical look....Pages 51-57
 Helicobacter pylori : oro-oral, orogastric transmission: a critical look at the evidence....Pages 58-67
Vectors for the transmission of Helicobacter pylori ....Pages 68-74
Front Matter....Pages 75-75
The host cell response to Helicobacter pylori attachment....Pages 77-83
Changes in intracellular signaling following Helicobacter pylori infection of gastric epithelial cells....Pages 84-89
 Helicobacter pylori – interactions with phagocytes....Pages 90-100
Th1/Th2 lymphocyte responses in Helicobacter infections....Pages 101-109
Epithelial cell turnover and apoptosis....Pages 110-122
Cytokine-enhanced, Helicobacter pylori -induced, epithelial cell apoptosis....Pages 123-130
Front Matter....Pages 131-131
Acid-adaptive mechanisms of gastric Helicobacter ....Pages 133-147
 Helicobacter pylori and gastroduodenal secretions....Pages 148-157
Relevant factors in regulating endocrine, parietal and chief cells....Pages 158-168
Histamine and Helicobacter pylori : are we closer to the answer?....Pages 169-175
The effect of Helicobacter pylori on enterochromaffin-like (ECL) cell function....Pages 176-187
Front Matter....Pages 131-131
Mast cells and duodenal bicarbonate secretion....Pages 188-194
The impact of Helicobacter pylori infection on gastric neuromuscular function in the rat; basic observations and clinical implications for our understanding of functional dyspepsia....Pages 195-205
Front Matter....Pages 207-207
What drives the pattern of activity of the inflammatory reaction? Differences in antrum and corpus....Pages 209-214
Defining atrophic gastritis and grading gastric atrophy: new challenges beyond the Sydney System....Pages 215-223
Cardia mucosa gastritis(carditis):pathogenesis,correlation with gastritis of other sites and clinicopathological relevance....Pages 224-231
Front Matter....Pages 233-233
 Helicobacter pylori and non-ulcer dyspepsia — a critical look....Pages 235-244
Implications of Helicobacter pylori : ‘test-and-treat’ approach in a primary-care setting....Pages 245-251
Prerequisites of an adequate approach to dyspepsia: differences between the west and the east....Pages 252-259
The Helicobacter pylori -non-steroidal anti-inflammatory drug interaction: consensus at last?....Pages 260-266
 Helicobacter pylori infection and coronary heart disease: a critical look....Pages 267-273
Pitfalls in Helicobacter pylori diagnosis....Pages 274-292
Front Matter....Pages 293-293
An overview of Helicobacter pylori epidemiology studies....Pages 295-307
Nitrogen oxides and the gastric precancerous process....Pages 308-314
 Helicobacter pylori -associated gastric cancer: is population-based screening and therapy realistic?....Pages 315-324
Gastric carcinogenesis: when is the point of no return?....Pages 325-335
Atrophy, metaplasia and dysplasia - a risk for gastric cancer: are they reversible?....Pages 336-353
Lessons from Ongoing Intervention Studies....Pages 354-361
Criteria for the diagnosis of mucosa-associated lymphoid tissue lymphoma....Pages 362-372
Early and long-term results of Helicobacter pylori cure of MALT lymphoma — what are the pitfalls....Pages 373-380
Front Matter....Pages 381-381
Nitroimidazole metabolism and resistance in Helicobacter pylori ....Pages 383-391
Front Matter....Pages 381-381
Bioavailability of antimicrobials after oral and parenteral administration....Pages 392-397
Antimicrobial resistance in Helicobacter pylori : a global overview....Pages 398-415
Does bismuth prevent antimicrobial resistance of Helicobacter pylori? ....Pages 416-425
Variability in the outcome of treatment of Helicobacter pylori infection: a critical analysis....Pages 426-440
Novel therapies for Helicobacter pylori eradication....Pages 441-455
Towards monotherapy - what progress? first results with a new single ‘triple’ capsule....Pages 456-461
Towards vaccination: what progress?....Pages 462-470
Front Matter....Pages 471-471
The future of Helicobacter pylori research: the agenda for microbiologists....Pages 473-482
The future of H. pylori research: the agenda for histopathologists....Pages 483-489
 Helicobacter pylori: the clinical agenda....Pages 490-496
Back Matter....Pages 499-507